Kilter Group’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.8K Sell
38
-42
-53% -$2.16K ﹤0.01% 1061
2026
Q1
$4.74K Buy
80
+8
+11% +$519 ﹤0.01% 636
2025
Q4
$4.44K Buy
+72
New +$4.41K ﹤0.01% 539
2025
Q3
Sell
-17
Closed -$1.36K 1296
2025
Q2
$1.36K Buy
+17
New +$1.42K ﹤0.01% 739

Other funds holding PBH

Kilter Group's PBH Position: Q2 2026 in Review

Kilter Group reduced its Prestige Consumer Healthcare (PBH) stake by 53% in Q2 2026, selling an estimated $2.16K and leaving 38 shares worth $1.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1061.

Kilter Group first reported a position in PBH in Q2 2025 and has held it in 4 quarters since. The position peaked at $4.74K in Q1 2026. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Kilter Group held 38 shares of Prestige Consumer Healthcare worth $1.8K as of Q2 2026.
  • Kilter Group sold 42 Prestige Consumer Healthcare shares in Q2 2026, an estimated $2.16K.
  • Prestige Consumer Healthcare made up ﹤0.01% of Kilter Group's portfolio in Q2 2026, its #1061 holding.
  • Kilter Group first reported a position in Prestige Consumer Healthcare in Q2 2025 and has held it in 4 quarters since.
  • Kilter Group's Prestige Consumer Healthcare position peaked at $4.74K in Q1 2026.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.